Theme

Register of 2024 public money · GF0704

Public health services

A category of general government spending, COFOG level 2 (Eurostat). In 2024: .

Broad definition: a causal study in the line

evaluated

At least one causal study is tied to this line, on all of it or on one of its rules; the line then counts in full, so this is an upper bound.

Strict definition: a single measure with its own cost and study

not yet evaluated

A spending category: the register holds no separate cost for the measures inside it, so none of its money counts under this definition.

10 causal studies are tied to this line, the latest from 2026. The share of public money under each definition is on the evaluations page.

Summary to come: this line is number 37 in the order of writing, by 2024 amount, in queue.csv.

Against the Haut-commissariat's perimeters of aid to companies:

  • not placed: the report lists no measure of this line

The perimeters, and the share of each with a causal study

The literature

The studies that touch this line

  • Guillaume E et al. (2017). Patient navigation to reduce social inequalities in colorectal cancer screening participation: A cluster randomized controlled trial. Preventive Medicine.

    • Design, as recorded: cluster randomised controlled trial
    • Goal measured: Develop prevention: raise organised cancer-screening participation (European targets; colorectal screening 50-74)
    • Impact: effect « The intervention mainly with phone navigation increased individual participation (OR=1.19 [1.10, 1.29]) »
    • Leakage: not informed
    • Permanence: not informed
  • Denis B et al. (2017). Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial. Revue d'épidémiologie et de santé publique.

    • Design, as recorded: randomised controlled trial
    • Goal measured: Develop prevention: raise organised cancer-screening participation (European targets; colorectal screening 50-74)
    • Impact: effect « participation was significantly higher in the two intervention groups than in the control group »
    • Leakage: not informed
    • Permanence: not informed
  • Thomas C. Buchmueller and Léontine Goldzahl (2018). The effect of organized breast cancer screening on mammography use: Evidence from France. Health Economics.

    • Design, as recorded: difference-in-differences on the 50-74 age eligibility
    • Goal measured: Develop prevention: raise organised cancer-screening participation (European targets; colorectal screening 50-74)
    • Impact: effect « France's organized screening program has reduced socioeconomic disparities in access to mammography »
    • Leakage: not informed
    • Permanence: not informed
  • Affret A et al. (2020). Effectiveness of the e-Tabac Info Service application for smoking cessation: a pragmatic randomised controlled trial. BMJ Open.

    • Design, as recorded: pragmatic randomised controlled trial
    • Goal measured: Improve population health: reduce daily smoking prevalence
    • Impact: no significant effect « Use of the e-TIS app was not associated with a higher rate of smoking cessation. »
    • Leakage: not informed
    • Permanence: not informed
  • Guignard R et al. (2021). Effectiveness of 'Mois sans tabac 2016': A French social marketing campaign against smoking. Tobacco Induced Diseases.

    • Design, as recorded: WEAK: survey regression of exposed vs non-exposed smokers
    • Goal measured: Improve population health: reduce daily smoking prevalence
    • Impact: effect « These analyses suggest the effectiveness of the 2016 Mois sans tabac intervention »
    • Leakage: not informed
    • Permanence: not informed
  • Berlin I et al. (2021). Financial incentives for smoking cessation in pregnancy: multicentre randomised controlled trial. BMJ.

    • Design, as recorded: multicentre randomised controlled trial (pilot, not a scaled programme)
    • Goal measured: Improve population health: reduce daily smoking prevalence
    • Impact: effect « Financial incentives to reward smoking abstinence compared with no financial incentives were associated with an increased abstinence rate in pregnant smokers. »
    • Leakage: not informed
    • Permanence: not informed
  • Delphine Teigné et al. (2024). Organized cervical cancer screening: A randomized controlled trial assessing the effect of sending invitation letters. Preventive Medicine.

    • Design, as recorded: three-arm cluster randomised controlled trial
    • Goal measured: Develop prevention: raise organised cancer-screening participation (European targets; colorectal screening 50-74)
    • Impact: effect « resulted in a modest increase in participation among non-adherent women six months later »
    • Leakage: not informed
    • Permanence: not informed
  • Thilly N et al. (2024). Effectiveness of a School- and Primary Care-Based HPV Vaccination Intervention: The PrevHPV Cluster Randomized Trial. JAMA Network Open.

    • Design, as recorded: cluster randomised trial, incomplete factorial
    • Goal measured: Develop prevention: vaccination coverage (95% infant coverage; influenza 65+)
    • Impact: mixed « At-school HPV vaccination significantly increased vaccination coverage. The trial did not show a significant effect for training GPs and education and motivation. »
    • Leakage: not informed
    • Permanence: not informed
  • Guignard R et al. (2026). Effectiveness of an in-office intervention to improve general practitioners' support for tobacco smoking cessation: results from a randomised controlled trial (TABAC-PRO). BMC Primary Care.

    • Design, as recorded: randomised controlled trial
    • Goal measured: an outcome that is not one of the line's goals; its reading has no colour and is not counted
    • Impact: effect « Providing simple paper-based tools was associated with a greater likelihood of GPs discussing smoking cessation with their patients. »
    • Leakage: not informed
    • Permanence: not informed
    • another outcome, not counted
  • Bocquier A et al. (2026). One-year impact on HPV vaccination coverage of a school- and primary care-based intervention: the PrevHPV cluster randomised trial. Scientific Reports.

    • Design, as recorded: cluster randomised trial
    • Goal measured: Develop prevention: vaccination coverage (95% infant coverage; influenza 65+)
    • Impact: effect « School-based vaccination was effective in increasing HPV VC in the medium term »
    • Leakage: not informed
    • Permanence: lasts « effective in increasing HPV VC in the medium term »

Each study is coded by this site from the phrase quoted beside each verdict: impact on the goal it measures, leakage to people the law does not target, and permanence where the aim is a lasting change. The rows are in criteria.csv and studies.csv.

Searches

When the literature was searched

  • 2026-10-04: every line, for causal evaluations of its measures and rules. Searched: the HAL, Crossref, OpenAlex, PubMed and IDEAS/RePEc catalogues of research and publishers' pages, line by line, and a general web search engine until its allowance ran out; some research departments' sites refused automated access, so a study they publish may have been missed (data/literature/gaps). Found: literature/studies.csv.

Back to every line of the register

Sources: Eurostat, Ministère de l'Économie et des Finances, Direction de la Sécurité sociale, and the publishers of the studies, each named in its panel.

The page is static HTML and reads in full without JavaScript. The script adds the tooltips, traces a flow through a diagram, opens in place the evidence kept on separate pages, shows and hides the diagrams on a phone, recomputes the wealth calculator, places you on the page that asks where you stand, and keeps the theme you pick: light, dark or high contrast.

Questions, ideas or corrections: open an issue at github.com/samoht/budget/issues. Who makes this site, and the corrections made to it, are on the Method page.

Every data file, with its columns, licence and checksum: the Data page. Every chart, by question: the index of the charts. Every line of the register: the register's index.

The evidence summaries of the register as they are written: Latest updates (Atom feed).

Text and data: Licence Ouverte / Open Licence 2.0, except third-party data, which keep their publishers' terms. Code: ISC. See LICENSE.md.

Version unreleased-ef7a7ba2, built on 2026-11-12 from ef7a7ba2.